Lukas Scheibler Net Worth & Insider Trades

Lukas Scheibler - CHIEF INNOVATION OFFICER, Apellis Pharmaceuticals, Inc

As of May 31, 2022

What is Lukas Scheibler's Net Worth?

The current estimated net worth of Apellis Pharmaceuticals, Inc's CHIEF INNOVATION OFFICER, Lukas Scheibler, is estimated to be about $3.86M . Lukas Scheibler owns about 40,358 units of Apellis Pharmaceuticals, Inc common stock. In the last 4 years at Apellis Pharmaceuticals, Inc, Lukas Scheibler has sold an estimated value of $2.67M worth.

What is Lukas Scheibler's Past Insider Trading?

Lukas Scheibler's largest purchase order was 11,496 units , worth over $159.22K on April 4, 2022. Lukas Scheibler's largest sale order was 11,496 units , worth over $632.85K on April 4, 2022. In total, Lukas Scheibler has made about 19 transactions over 4 years of their time at Apellis Pharmaceuticals, Inc. Lukas Scheibler usually trades in February, with the busiest year in 2022. The most recent transaction was a sale order of 11,875 units , worth over $430K on May 31, 2022.

Lukas Scheibler

Date Range: All Time
Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

What is Lukas Scheibler's' Mailing Address?

  • Mailing address is C/o Apellis Pharmaceuticals, Inc. 6400 Westwind Way, Suite A Crestwood KY 40014 KY

Apellis Pharmaceuticals, Inc Executive Compensation

Name
Year
Salary
Bonus
Stock Awards
Option Awards
Other Compensation
Total
Cedric Francois, M.D., Ph.D. 2020 $618,769 $429,687 $1,523,844 $6,703,125 - $9,275,425
Cedric Francois, M.D., Ph.D. 2019 $560,019 $427,893 - $3,279,270 - $4,267,182
Cedric Francois, M.D., Ph.D. 2018 $550,000 $381,562 - $3,127,600 $15,378 $4,074,540
Timothy Sullivan 2020 $430,269 $244,688 $518,129 $2,279,063 $13,000 $3,485,149
Timothy Sullivan 2019 $386,423 $214,730 - $1,108,650 $9,500 $1,719,303
Timothy Sullivan 2018 $380,000 $190,000 - $279,250 $10,502 $859,752
Pascal Deschatelets, Ph.D. 2020 $423,500 $239,062 $415,594 $1,828,125 $11,801 $2,918,082
Pascal Deschatelets, Ph.D. 2019 $404,077 $252,608 - $1,108,650 $55,893 $1,821,228
Pascal Deschatelets, Ph.D. 2018 $400,000 $225,000 - $1,228,700 $8,657 $1,862,357
Nur Nicholson 2020 $138,462 $150,068 - $2,648,750 $84,874 $3,022,154
Adam Townsend 2020 $430,038 $217,500 $415,594 $1,828,125 $9,750 $2,901,007
No matching records found

Source: https://www.sec.gov/Archives/edgar/data/1492422/000119312521126688/d887358ddef14a.htm

What are Apellis Pharmaceuticals, Inc's Past Insider Trades?

Apellis Pharmaceuticals, Inc's most recent insider trade came on December 7, 2022 by Adam Townsend who sold 10,000 units worth $327.35K . In the last 5 years, insiders at Apellis Pharmaceuticals, Inc have sold an estimated value of $58.14M and bought an estimated value of $96.26M worth of shares. Insider trading is most common in February, with the busiest year in 2022. The most active traders at the company are Federico Grossi, Chief Medical Officer,  Alec MacHiels, Director,  and Cedric Francois, Chief Executive Officer .

Apellis Pharmaceuticals, Inc. Insider Trades

Date Range: All Time
Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1